Heart Rate Variability as a Digital Biomarker

HRV describes the variation in time between heartbeats. It is the most popular measure in consumer wearables and one of the least used as a registered clinical trial endpoint.

Status
Exploratory
Unit
ms (RMSSD) and others
Data type
Composite
Sensor
Optical PPG or single lead ECG
Worn
Wrist

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Established
Analytical validation
Emerging
Clinical validation
Limited

Well characterised physiologically with meta-analytic support for an association with mortality, but weakly represented as a registered trial endpoint and highly sensitive to how it is computed. Comparable within a person on one device, not between devices or people.

What is Heart Rate Variability

Heart rate variability is the variation in the interval between consecutive heartbeats. It arises from the balance between sympathetic and parasympathetic input to the heart, which is why it is used as an indirect window on autonomic function. Reduced variability is associated with worse outcomes across a range of conditions, and meta analysis supports an association with mortality.

The gap between that evidence and how the measure is used commercially is the central issue on this page. Heart rate variability is the headline metric of recovery and readiness scores in consumer wearables, yet in the public registry of digital endpoints it appears in strikingly few registered trials, far fewer than its popularity would suggest. This library records that discrepancy rather than smoothing it over, because it is the clearest example in digital health of a measure whose commercial adoption has outrun its endpoint record.

How it is measured

The measurement starts from a series of beat intervals, ideally from electrocardiography, where each beat is timed precisely. Optical sensors estimate the same intervals from the pulse waveform, which introduces additional variability of its own. From that series, algorithms compute time domain metrics such as the root mean square of successive differences, frequency domain metrics that split variability into bands, and non linear metrics.

The critical detail is that the number depends heavily on how it was produced. Recording length, time of day, posture, breathing rate, artefact filtering and the specific metric chosen all change the result. Consumer devices typically compute variability over a window during sleep, using proprietary processing that differs between manufacturers and can change with a firmware update.

Clinical use

The defensible uses are within a person and over time. Tracking an individual's variability across weeks on a single device can reveal physiological strain, illness onset or response to training, and studies designed that way are on reasonable ground. Research applications include autonomic function in diabetes and neurological disease, cardiac risk stratification, and stress and recovery research.

In trials it appears more often as an exploratory or supporting measure than as a primary endpoint. Because it has no questionnaire counterpart, it is reported alongside instruments such as the Perceived Stress Scale or the WHO-5 Well-Being Index when it is being used in a psychological context, and that pairing is important: it makes clear that the sensor is measuring autonomic activity while the questionnaire measures the experience.

Regulatory status

No regulatory qualification as a clinical trial endpoint. Consumer recovery and readiness scores built on heart rate variability are wellness features and are not cleared measurements of recovery, stress or wellbeing.

Limitations

Values are not comparable between devices, between recording lengths, or between metrics, and pooling them is a common analytical error. Breathing rate strongly influences the frequency domain measures, so a participant who breathes differently will produce different variability without any change in autonomic state.

The construct is also over interpreted. Variability responds to exercise, alcohol, illness, sleep debt, ambient temperature and posture, so labelling a decline as stress or poor recovery attributes a specific psychological cause to a non specific physiological signal. Consumer readiness scores are built on that attribution and should not be treated as validated measurements of recovery or wellbeing.

References

  • Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017. pubmed.ncbi.nlm.nih.gov
  • Laborde S, et al. Heart rate variability and cardiac vagal tone in psychophysiological research: recommendations for experiment planning, data analysis and data reporting. Front Psychol. 2017. pubmed.ncbi.nlm.nih.gov
  • Jarczok MN, et al. Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations. Neurosci Biobehav Rev. 2022. pubmed.ncbi.nlm.nih.gov
  • Miller DJ, et al. A validation of six wearable devices for estimating sleep, heart rate and heart rate variability in healthy adults. Sensors. 2022. pubmed.ncbi.nlm.nih.gov
Related instruments

No questionnaire measures heart rate variability. It is paired with the Perceived Stress Scale and the WHO-5 Well-Being Index when used in a psychological context, and the pairing is deliberate: the sensor measures autonomic activity while the questionnaire measures the experience.

Use case
Monitoring
Collect Heart Rate Variability and other digital biomarkers in one workflow. Or turn your research into a new digital biomarker?
Capture wearable physiology alongside validated stress and wellbeing instruments in one study workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.